This inventor holds 12 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Virginia Commonwealth University, Organix, Inc.. Active years: 1999-2024.
Company Filing History:
10 out of 3,690 
2 out of 419 
1 out of 17 
Years Active: 1999-2024
Title: The Innovative Contributions of George Kunos
Introduction
George Kunos is a prominent inventor based in Bethesda, MD (US), known for his significant contributions to the field of cannabinoid research. With a total of 12 patents to his name, Kunos has made remarkable strides in developing therapeutic compounds that target cannabinoid receptors.
Latest Patents
Among his latest patents, Kunos has developed cannabinoid receptor mediating compounds. These compounds consist of a CB receptor mediating scaffold conjugated to a second therapeutic scaffold, which may include pharmaceutically acceptable salts or esters. This innovative approach aims to enhance the efficacy of cannabinoid-based therapies.
Career Highlights
Kunos has had a distinguished career, working with esteemed institutions such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Virginia Commonwealth University. His work has significantly advanced the understanding of cannabinoid receptors and their potential therapeutic applications.
Collaborations
Throughout his career, Kunos has collaborated with notable colleagues, including Malliga R. Iyer and Resat Cinar. These collaborations have fostered a rich environment for innovation and research in cannabinoid science.
Conclusion
George Kunos's contributions to cannabinoid research and his impressive portfolio of patents underscore his role as a leading inventor in the field. His work continues to pave the way for new therapeutic options and advancements in medical science.